Hypopharyngeal Cancer Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.The Management of Metastatic Neck Nodes in N2/3 Hypopharyngeal Squamous Cell Carcinoma
Condition: Hypopharyngeal Carcinoma Interventions: Drug: Docetaxel; Drug: Cisplatin; Drug: Capecitabine; Radiation: Concomitant chemoradiotherapy; Procedure: Surgery Sponsors: Eye & ENT Hospital of Fudan University; Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Shandong Provincial Hospital; Harbin Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2022 Category: Research Source Type: clinical trials
The Management of Metastatic Neck Nodes in N2/3 Hypopharyngeal Squamous Cell Carcinoma
Condition: Hypopharyngeal Carcinoma Interventions: Drug: Docetaxel; Drug: Cisplatin; Drug: Capecitabine; Radiation: Concomitant chemoradiotherapy; Procedure: Surgery Sponsors: Eye & ENT Hospital of Fudan University; Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Shandong Provincial Hospital; Harbin Medical University Third Affiliated Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2022 Category: Research Source Type: clinical trials
Induction Chemotherapy and Toripalimab Followed by Radiotherapy in Unresectable Laryngeal/Hypopharyngeal Carcinoma
Conditions: Laryngeal Cancer; Hypopharyngeal Cancer Intervention: Drug: Toripalimab Sponsor: Fudan University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 15, 2022 Category: Research Source Type: clinical trials
